CIPRIANI, ALBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.238
EU - Europa 4.320
AS - Asia 4.226
SA - Sud America 1.446
AF - Africa 1.328
OC - Oceania 130
Continente sconosciuto - Info sul continente non disponibili 63
Totale 18.751
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.538
IT - Italia 1.690
SG - Singapore 1.239
BR - Brasile 977
CN - Cina 760
HK - Hong Kong 659
DE - Germania 308
VN - Vietnam 233
FI - Finlandia 221
NL - Olanda 214
SE - Svezia 214
PL - Polonia 166
RU - Federazione Russa 129
GB - Regno Unito 116
FR - Francia 110
IN - India 94
AR - Argentina 82
KR - Corea 82
EC - Ecuador 74
MX - Messico 69
TR - Turchia 68
AT - Austria 63
ES - Italia 61
ZA - Sudafrica 59
PY - Paraguay 57
IQ - Iraq 56
ID - Indonesia 55
IE - Irlanda 53
UZ - Uzbekistan 50
KE - Kenya 49
UA - Ucraina 49
AO - Angola 47
RO - Romania 47
AZ - Azerbaigian 45
AE - Emirati Arabi Uniti 44
CI - Costa d'Avorio 44
RS - Serbia 44
CZ - Repubblica Ceca 43
LU - Lussemburgo 43
NI - Nicaragua 43
PE - Perù 43
BY - Bielorussia 42
GR - Grecia 42
IL - Israele 42
IR - Iran 42
IS - Islanda 42
CR - Costa Rica 41
CW - ???statistics.table.value.countryCode.CW??? 41
LV - Lettonia 41
MY - Malesia 41
UY - Uruguay 41
MA - Marocco 40
PA - Panama 40
TT - Trinidad e Tobago 40
VE - Venezuela 40
AL - Albania 39
CO - Colombia 39
CV - Capo Verde 39
MD - Moldavia 39
SO - Somalia 39
CH - Svizzera 38
DZ - Algeria 38
JP - Giappone 38
LY - Libia 38
GA - Gabon 37
GT - Guatemala 37
HN - Honduras 37
MK - Macedonia 37
MW - Malawi 37
TH - Thailandia 37
HU - Ungheria 36
JM - Giamaica 36
KG - Kirghizistan 36
CA - Canada 35
CL - Cile 35
DK - Danimarca 35
EG - Egitto 35
HR - Croazia 35
KZ - Kazakistan 35
MG - Madagascar 35
PS - Palestinian Territory 35
PT - Portogallo 35
SI - Slovenia 35
SK - Slovacchia (Repubblica Slovacca) 35
UG - Uganda 35
ZW - Zimbabwe 35
AD - Andorra 34
LB - Libano 34
ML - Mali 34
MR - Mauritania 34
KH - Cambogia 33
TW - Taiwan 33
BB - Barbados 32
BF - Burkina Faso 32
BW - Botswana 32
CD - Congo 32
ET - Etiopia 32
NP - Nepal 32
SD - Sudan 32
BZ - Belize 31
Totale 17.202
Salva come PNG Salva come JPEG
Città #
Fairfield 834
Singapore 808
Ashburn 797
Hong Kong 628
Chandler 538
Woodbridge 322
Houston 314
Beijing 299
Santa Clara 298
Seattle 283
Cambridge 279
Wilmington 221
Milan 201
Boardman 176
Padova 167
Munich 144
Ann Arbor 138
Los Angeles 132
Bytom 118
San Diego 113
Chicago 101
Helsinki 93
Rome 88
Princeton 87
Medford 85
Ho Chi Minh City 84
Hefei 82
São Paulo 77
Turku 77
New York 64
Des Moines 60
Buffalo 58
Abidjan 44
Hanoi 44
Tashkent 44
Managua 43
Baku 42
Bologna 42
Turin 42
Roxbury 41
Dublin 39
Luanda 39
Nairobi 39
Salt Lake City 37
San José 37
Seoul 37
Vienna 37
Libreville 36
Montevideo 36
Panama City 36
Riga 36
Villafranca Padovana 36
Antananarivo 34
Bamako 34
Lappeenranta 34
Padua 34
Praia 34
Willemstad 33
Andorra la Vella 32
Kampala 32
Nouakchott 32
Phnom Penh 32
Bridgetown 31
Castries 31
Dakar 31
Bishkek 30
Amman 29
Dushanbe 29
Guayaquil 29
Harare 29
Johannesburg 29
Redondo Beach 29
Rio de Janeiro 29
Minsk 28
Nuremberg 28
Conakry 27
Kingstown 27
Lilongwe 27
Lusaka 27
Reykjavik 27
Tripoli 27
Accra 26
Brooklyn 26
Kinshasa 26
Lima 26
Ulan Bator 26
London 25
Nassau 25
Noumea 25
Roseau 25
Verona 25
Hargeisa 24
Naples 24
Podgorica 24
Stockholm 24
Belo Horizonte 23
Chisinau 23
Dallas 23
Guatemala City 23
Luxembourg 23
Totale 9.894
Salva come PNG Salva come JPEG
Nome #
'Hot phase' clinical presentation in arrhythmogenic cardiomyopathy 411
The 2020 “Padua Criteria” for Diagnosis and Phenotype Characterization of Arrhythmogenic Cardiomyopathy in Clinical Practice 295
Morphofunctional abnormalities of mitral annulus and arrhythmic mitral valve prolapse 256
Ventricular arrhythmias in young competitive athletes: Prevalence, determinants, and underlying substrate 229
Whole-Exome Sequencing Identifies Pathogenic Variants in TJP1 Gene Associated With Arrhythmogenic Cardiomyopathy 221
Relative apical sparing in cardiac amyloidosis is not always explained by an amyloid gradient 208
Predictive value of exercise testing in athletes with ventricular ectopy evaluated by cardiac magnetic resonance 199
Burden of ventricular arrhythmias at 12-lead 24-hour ambulatory ECG monitoring in middle-aged endurance athletes versus sedentary controls 192
Anatomical Predictors of Pacemaker Dependency after Transcatheter Aortic Valve Replacement 190
Proposed diagnostic criteria for arrhythmogenic cardiomyopathy: European Task Force consensus report 189
The hazard of (sub)therapeutic doses of anticoagulants in non-critically ill patients with Covid-19: the Padua province experience 187
Arrhythmic Mitral Valve Prolapse and Sudden Cardiac Death 184
Transthoracic 3D echocardiography imaging of transcatheter pacing system 178
Right Ventricular Junctional Late Gadolinium Enhancement Correlates With Outcomes in Pulmonary Hypertension 177
Relationship between electrocardiographic findings and cardiac magnetic resonance phenotypes in arrhythmogenic cardiomyopathy 176
Arrhythmogenic Right Ventricular Cardiomyopathy: Characterization of Left Ventricular Phenotype and Differential Diagnosis With Dilated Cardiomyopathy 165
Diagnostic-therapeutic care pathways for patients with cardiac amyloidosis - SIC/ANMCO Consensus Document. Edited by the Italian Cardiac Amyloidosis Network (RIAC) 164
Arrhythmic profile and 24-hour QT interval variability in COVID-19 patients treated with hydroxychloroquine and azithromycin 162
Worldwide Survey of COVID-19 Associated Arrhythmias 157
Correlation between exercise addiction and attitude of competitive athletes towards cardiac preparticipation evaluation 155
The "Padua classification" of cardiomyopathies: Combining pathobiological basis and morpho-functional remodeling 154
Effective and safe lead extraction using the bidirectional rotational Evolution® sheath in a child with congenital heart disease 150
Exercise addiction in athletes: Comparing two assessment instruments and willingness to stop exercise after medical advice 150
Anti-arrhythmic therapy in athletes 149
529Relationship between ventricular mechanics and fibro-fatty replacement on cardiac magnetic resonance in arrhythmogenic cardiomyopathy 148
Response to letters regarding article, "arrhythmic mitral valve prolapse and sudden cardiac death" 147
Response to Letters Regarding Article, "Arrhythmic Mitral Valve Prolapse and Sudden Cardiac Death" 146
Burden of premature atrial beats in middle-aged endurance athletes with and without lone atrial fibrillation versus sedentary controls 144
Cardiac magnetic resonance imaging of arrhythmogenic cardiomyopathy: evolving diagnostic perspectives 142
Left Ventricular Non-Compaction: Evolving Concepts 142
Time course of intramyocardial hematoma secondary to Ellis type III coronary rupture during chronic total occlusion intervention 142
Interpretation and management of premature ventricular beats in athletes: An expert opinion document of the Italian Society of Sports Cardiology (SICSPORT) 141
Determinants of Ventricular Arrhythmias in Mitral Valve Prolapse 139
A Comprehensive Analysis of Non-Desmosomal Rare Genetic Variants in Arrhythmogenic Cardiomyopathy: Integrating in Padua Cohort Literature-Derived Data 138
Diagnosis of arrhythmogenic cardiomyopathy: The Padua criteria 138
Screening young athletes for diseases at risk of sudden cardiac death: role of stress testing for ventricular arrhythmias 137
Papillary Muscles Abnormalities in Athletes With Otherwise Unexplained T-Wave Inversion in the ECG Lateral Leads 137
Causes of sudden cardiac arrest and death and the diagnostic yield of sport preparticipation screening in children 136
Hypertrophic Cardiomyopathy and Primary Restrictive Cardiomyopathy: Similarities, Differences and Phenocopies 136
475Ventricular arrhythmias at 24-hours ambulatory ECG monitoring: young versus senior competitive athletes 135
Filamin C variant-associated Cardiomyopathy: A Pooled Analysis of Individual Patient Data to Evaluate the Clinical Profile and Risk of Sudden Cardiac Death 134
351Cannabinoids-induced toxic myocarditis underlying apical ballooning syndrome: a case proven by combined cardiac magnetic resonance and endomyocardial biopsy 131
Diagnosis of arrhythmogenic cardiomyopathy: 20 years of progress and innovation 130
Electrocardiographic predictors of primary ventricular fibrillation and 30-day mortality in patients presenting with st-segment elevation myocardial infarction 130
The electrocardiographic "triangular QRS-ST-T waveform" pattern in patients with ST-segment elevation myocardial infarction: Incidence, pathophysiology and clinical implications 129
Myocardial Tissue Characterization in Arrhythmogenic Cardiomyopathy: Comparison Between Endomyocardial Biopsy and Cardiac Magnetic Resonance 129
P658Prevalence and determinant of ventricular arrhythmias at 24-hours ambulatory ECG monitoring in young competitive athletes and sedentary controls 126
Clinical profile and long-term follow-up of a cohort of patients with desmoplakin cardiomyopathy 123
Arrhythmogenic Cardiomyopathy and Sports Activity 122
P359A very unusual cause of exercise-induced ventricular arrhythmias in the athlete 121
Change in prevalence of ATTR variants in Italy - Results from a National Survey 121
Cardiac injury and mortality in patients with Coronavirus disease 2019 (COVID-19): insights from a mediation analysis 120
Contemporary diagnostic approach to arrhythmogenic cardiomyopathy: The three-step work-up 119
Cardiac injury and COVID-19 associated coagulopathy in patients with acute SARS-CoV-2 pneumonia: A rotational thromboelastometry study 119
Role of Cardiac Magnetic Resonance Imaging in the Evaluation of Athletes with Premature Ventricular Beats 119
The 'Padua classification' of cardiomyopathies into three groups: hypertrophic/restrictive, dilated/hypokinetic, and scarring/arrhythmogenic 117
Arrhythmogenic Cardiomyopathy—Current Treatment and Future Options 117
Differential diagnosis of arrhythmogenic cardiomyopathy: phenocopies versus disease variants 116
The "Subtle" connection between development of cardiac implantable electrical device infection and survival after complete system removal: An observational prospective multicenter study 115
Incidental cardiac uptake of 99mTc-diphosphonates is predictive of poor outcome: data from 9616 bone scintigraphies 114
Myocardial rupture after myocardial infarction and cardiac magnetic resonance: mechanism beyond tissue characterization 113
How to look at adult congenital left ventricular outpouchings: a step-by-step approach using cardiac magnetic resonance 113
Evolving Diagnostic Criteria for Arrhythmogenic Cardiomyopathy 112
Strength of clinical indication and therapeutic impact of the implantable cardioverter defibrillator in patients with hypertrophic cardiomyopathy 112
Heart failure due to adrenergic myocardial toxicity from a pheochromocytoma. 111
Myocardial substrates underlying early ventricular arrhythmias in ST-elevation acute myocardial infarction: the role of cardiac magnetic resonance 111
Arrhythmogenic Left Ventricular Cardiomyopathy: Genotype-Phenotype Correlations and New Diagnostic Criteria 111
Redefining risk or mislabeling disease? Revisiting the NDLVC concept 111
REPRODUCIBILITY OF VENTRICULAR ARRHYTHMIAS AT EXERCISE TESTING FOR PREDICTION OF NON-ISCHEMIC LEFT VENTRICULAR SCAR IN ATHLETES 110
Myocardial strain assessed by cardiac magnetic resonance in acute myocardial infarction: possible correlation between feature tracking and tissue characterization. 110
Cardiovascular magnetic resonance: What clinicians should know about safety and contraindications 110
Scarring/arrhythmogenic cardiomyopathy 108
New prognostic parameters in non-ischemic dilated cardiomyopathy: Comparison between myocardial fibrosis and myocardial strain assessed by cardiac magnetic resonance 108
Cardiac Magnetic Resonance Imaging in Myocarditis 108
P384Ventricular arrhythmias and left ventricular dilatation in a young pregnant woman: the additional diagnostic value of cardiovascular magnetic resonance 107
The pathobiologic mechanisms and the prognostic meaning of T-wave inversion in acute myocarditis. A study performed by cardiac magnetic resonance 106
Relationship between CMR findings and tissue characterization in ARVC: a link from ECG to imaging 106
Diagnostic Yield of Non-Invasive Testing in Patients with Anomalous Aortic Origin of Coronary Arteries: A Multicentric Experience 105
Role of ventricular tachycardia ablation in arrhythmogenic right ventricular cardiomyopathy 104
Ventricular arrhythmias in mitral valve prolapse: New explanations for an old problem 104
Predictors of Left Ventricular Scar Using Cardiac Magnetic Resonance in Athletes With Apparently Idiopathic Ventricular Arrhythmias 104
The 2023 European Task Force Criteria for Diagnosis of Arrhythmogenic Cardiomyopathy: Historical Background and Review of Main Changes 103
Cardiac Magnetic Resonance—Detected Acute Myocardial Edema as Predictor of Favourable Prognosis: A Comprehensive Review 102
P1596Tissue characterization in Arrhythmogenic Cardiomyopathy: diagnostic impact of combined endomyocardial biopsy and cardiac magnetic resonance approach 102
Clinical management of a pregnant woman with Filamin C cardiomyopathy 102
Impact of coronavirus disease-19 outbreak on arrhythmic events and mortality among implantable cardioverter defibrillator patients followed up by remote monitoring: a single center study from the Veneto region of Italy 101
[Mitral valvuloplasty in a patient with congenital kyphoscoliosis: case report and literature review] 101
Natural History of Arrhythmogenic Cardiomyopathy 101
Importance of genotype for risk stratification in arrhythmogenic right ventricular cardiomyopathy using the 2019 ARVC risk calculator 100
Dealing With High-Risk AL Amyloidosis Patients: A Single Hematologic Center Experience 100
Light-chain cardiac amyloidosis for the non-expert: pearls and pitfalls 99
Congenital Pericardial Agenesis in Asymptomatic Individuals: Tips for the Diagnosis 98
Prognostic value of left ventricular blood stasis in patients with acute myocardial infarction: A cardiac magnetic resonance study 98
Left Ventricular Thrombosis Following Apical Myocardial Infarction: Might Cardiac Magnetic Resonance Strain Analysis Tell Us Something? 97
Incidence and risk factors for pacemaker implantation in light-chain and transthyretin cardiac amyloidosis 96
Hospitalization-based epidemiology of systemic and cardiac amyloidosis in the Veneto Region, Italy 95
Phenotypic Expression and Clinical Outcomes in Patients With Arrhythmogenic Cardiomyopathies 94
P377Arrhythmogenic cardiomyopathy in epidermolysis bullosa: are desmosomes at fault for both? 94
Negative bone scintigraphy in wild-type transthyretin cardiac amyloidosis 94
Cardiac rupture in acute myocardial infarction: a cardiac magnetic resonance study 93
Totale 13.552
Salva come PNG Salva come JPEG
Categoria #
all - tutte 66.119
article - articoli 65.098
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.021
Totale 132.238
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021983 0 0 0 99 11 84 39 71 187 223 177 92
2021/20221.465 47 149 158 92 110 122 71 145 153 47 95 276
2022/20231.226 208 123 51 106 157 142 20 109 154 30 82 44
2023/20241.283 36 145 102 129 102 107 143 86 66 56 153 158
2024/20255.218 48 356 222 226 474 207 362 452 446 319 763 1.343
2025/20267.485 1.173 1.548 2.830 1.934 0 0 0 0 0 0 0 0
Totale 19.097